ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Francisco, CA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near San Francisco, CA, USA:

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

The goal of this cluster randomized clinical trial is to test the efficacy of messaging interventions to increase booster vaccine uptake in adults in...

Enrolling
COVID-19
Behavioral: Vaccine Acceptance Question
Behavioral: Vaccine Messaging
University of California San Francisco (UCSF)
University of California San Francisco (UCSF)

San Francisco, California, United States and 6 other locations

by whole-body PET-CT imaging in participants with convalescent COVID-19. Up to 20 participants will be enrolled over an accrual per...

Enrolling
Covid19
SARS-CoV Infection
Drug: [18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)

Early Phase 1

CellSight Technologies

San Francisco, California, United States

This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: Remdesivir

Phase 3

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

San Francisco, California, United States and 123 other locations

a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =\<2500 U/mL SARS-CoV-2 S antibody concentr...

Active, not recruiting
COVID-19
Kidney Transplant
Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine

Phase 2

National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Allergy and Infectious Diseases (NIAID)

San Francisco, California, United States and 5 other locations

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting
COVID-19
Influenza, Human
Biological: BNT162b2 (Omi XBB.1.5)/RIV
Biological: RIV

Phase 2

Pfizer
Pfizer

Walnut Creek, Colorado, United States of America and 29 other locations

This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b4 10 µg
Biological: BNT162b4 15 µg

Phase 1

BioNTech
BioNTech

Walnut Creek, Colorado, United States of America and 16 other locations

Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 with \[18F\]FP-R01-MG-F2 wi...

Enrolling
Covid19 Pneumonia
Primary Sclerosing Cholangitis
Drug: [18F]FP-R01-MG-F2

Early Phase 1

Stanford University
Stanford University

Stanford, California, United States

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Active, not recruiting
COVID-19
Influenza
Biological: COVID-19 Vaccine
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

Walnut Creek, Colorado, United States of America and 157 other locations

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechani...

Enrolling
Severe Acute Respiratory Syndrome Coronavirus 2
Severe Acute Respiratory Infection
Combination Product: NA-831and Dexamethasone
Drug: Drug: NA-831

Phase 2, Phase 3

NeuroActiva

San Francisco, California, United States and 30 other locations

the study vaccine (called COMIRNATY) for the potential prevention of COVID-19. This study is seeking participants who:1. Are age \<...

Enrolling
Myocarditis
Diagnostic Test: Cardiac Imaging

Phase 4

Pfizer
Pfizer

Palo Alto, California, United States and 35 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems